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Insulin receptor preparations from human placenta t various tates of purity were shown to catalyze insu- 
lin-stimulated phosphate incorporation from [y-3ZP]ATP into endogenous (membrane) and exogenous 
phosphatidylinositol. Our data suggest that the insulin receptor associated protein (tyrosine) kinase can act 
as a phosphatidylinsositol kinase, and that this mechanism ay be of physiological importance in signal 
transduction ofinsulin. 
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1. INTRODUCTION 
The physiological significance of the insulin 
receptor-associated tyrosine protein kinase in the 
biological actions of insulin is not yet clear. 
Although various exogenous proteins like histone, 
casein and others were shown to be 
phosphorylated by the receptor kinase none of 
them appeared likely as a physiological substrate. 
The insulin-stimulated phosphorylation of actin by 
placental membranes [l] may perhaps be more 
relevant in this respect. These experiments further 
indicated that actin was phosphorylated at serine 
residues rather than at tyrosine residues when 
crude receptor preparation, not purified by lectin 
affinity chromatography, was used [2]. This sug- 
gested, in accordance with [3] the involvement of 
(a) serine-specific protein kinase(s) which in some 
way seem(s) to be activated by insulin through the 
receptor-associated tyrosine kinase. Our studies 
reported here may shed some new light on these 
regulatory interrelationships. 
of insulin binding activity (IBA), protein deter- 
mination, SDS-polyacrylamide gel electrophoresis 
was done as in [1,4]. Phosphatidylinositol (soy- 
bean, approx. 98%), phosphoinositides, phos- 
phatidylserine, phosphatidylethanolamine were 
from Sigma (St Louis, MO); for other reagents and 
methods see [ 1,4]. 
2.1. Standard phosphorylation assay 
2. MATERIALS AND METHODS 
Solubilization and purification of the insulin 
receptor from human placenta membranes, assay 
The standard incubation medium consisted of 
50pM Tris/HCl, pH 7.4, 10 mM MgClz, 5 mM 
MnC12, 2.5 mM vanadate, 50pM [T-~~P]ATP 
(2.5-15 &i), and the other components as 
specified in the figure and table legends. The final 
volume was 100~1. Phospholipids were dried 
under a stream of nitrogen, evaporated in vacua, 
and suspended by brief sonification in 50 mM 
Tris/maleate, pH 7.4. The samples were prein- 
cubated 25 min without or with insulin, 5 x 
lo-’ M, before the reaction was commenced by the 
addition of [Y-~~P]ATP. After 25 min at 23°C the 
reaction was terminated by addition of 300 ~1 1 N 
HCl. Lipids were extracted with 300~1 
chloroform/methanol, 2: 1 (v/v) and then with 
300~1 chloroform. The extracts were pooled and 
washed three times with 500 ,ul methanol/l N HCl, 
1: 1 (v/v). Total lipid radioactivity of the 
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chloroform extract was measured by liquid scin- 
tillation spectrometry. 
2.2. Separation of lipids by TLC 
Lipids were separated on silica gel 60 thin layer 
plates (Merck, Darmstadt) which were impreg- 
nated with 1% potassium oxalate in methanol/ 
water, 2: 3 (v/v), dried at room temperature and 
activated at 110°C for 15 min. 20 /cl samples of the 
lipid extracts were applied to the plates and the 
chromatograms were developed in a paper lined 
chamber with chloroform/acetone/methanol/ 
acetic acid/water, 40: 15 : 13 : 12: 8, by vol. [5]. The 
lipids were detected with iodine vapor, and the 32P- 
labelled spots by autoradiography on Kodak 
X-Omat film. The spots were scraped off and 
counted for radioactivity in a liquid scintillation 
counter. 
3. RESULTS 
When a partially purified insulin receptor 
preparation from placenta membranes (wheat 
germ eluate [l]) was incubated with [T-~~P]ATP 
x10s3cpm 
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Fig. 1. Phosphorylation of phosphatidylinositol by a 
partially purified insulin receptor preparation from 
human placenta. PtdIns, 1.4 mg was incubated with 
‘wheat germ eluate’ (1) corresponding to 0.63 mU/IBA 
in the standard incubation mixture as in section 2. The 
final volume was 700 ~1, and 100 pl samples were taken 
at the times indicated for lipid extraction and scintilla- 
tion counting. There was essentially no 32P-incorpora- 
tion when the receptor preparation was boiled prior to 
Fig.2. Thin layer chromatographic analysis of “P- 
labelled phosphoinositides. Phosphorylation, extrac- 
tion, separation and autoradiography of lipids was done 
as in section 2. (A,B) Triton X-100 solubilized placenta 
membranes corresponding to 0.5 mg protein per assay 
without (A) or with (B) addition of PtdIns, 1.6 mg/ml. 
(C) Insulin receptor purified on Sepharose 6B-Cl and 
sucrose density gradient centrifugation (IBA 10 mU/mg 
[4]) corresponding to 9 pg protein per assay, and PtdIns 
(2 mg/ml). DPI, PtdIns 4P; TPI, PtdIns 4,5 Pz. 
Quantitative data on 32P-labelling of the respective 
phosphoinositides calculated as cpm incorporated per pg 
incubation. protein are given at the bottom of the figure. 
and phosphatidylinositol (PtdIns) there was a 
rapid, time-dependent incorporation of 32P- 
radioactivity into the lipid extracts which was 
clearly increased by insulin (fig.1). As shown in 
fig.2 separation of the lipids on TLC, and auto- 
radiography yielded two labelled spots, a major 
one migrating with phosphatidylinositol 4-phos- 
phate (PtdIns 4P) and a smaller one migrating with 
phosphatidylinositol 4,5-bisphosphate (PtdIns 4,5 
P2). The spot remaining at the origin was not iden- 
tified. The labelling of the phosphoinositides, par- 
ticularly of PtdIns 4P was increased by insulin. 
Quantitative data on 32P-incorporation into the 
corresponding fractions scraped from the plate are 
given in the lower panel of fig.2. It seems worth 
mentioning that insulin also clearly stimulated the 
phosphorylation of endogenous PtdIns of the 
membranes. It should be further noted that insulin 
receptor preparations after several purification 
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Fig.3. Phosphorylation of phosphatidylinositol as a 
function of protein concentration. Phosphorylation was 
carried out in the standard assay system containing 
PtdIns (1.6 mg/ml) and increasing amounts of highly 
purified insulin receptor (Sepharose 6B-Cl-sucrose 
gradient centrifugation - Sepharose 6B-Cl-hydroxyapa- 
tite 141, IBA > 50 mU/mg protein) corresponding to the 
protein concentrations indicated on the abscissa. Lipids 
were extracted as indicated in section 2 and counted for 
radioactivity. 
steps still effected insulin-stimulatable and protein 
concentration dependent PtdIns phosphorylation 
(figs.2,3) suggesting that this activity is related to 
the receptor-associated protein kinase. This was 
supported by the finding that the stimulation by in- 
sulin of the phosphorylation of the receptor &sub- 
unit and of PtdIns displayed the same dose- 
response relationship (fig.4). Phosphorylation of 
PtdIns was dependent on substrate concentrations 
reaching near saturation at 2 mglml (data not 
shown). 
4. DISCUSSION 
Receptor-mediated hydrolysis of the 
phosphoinositides by phospholipase C plays a key 
role in signal transduction of many hormones and 
agonists that act through calcium as intracellular 
mediator (for review see 163). The reaction pro- 
ducts: inositol trisphosphate and diacylglycerol 
Inwlln [Ml 
Fig.4. Insulin dose-response relationship of the 
phosphorylation of phosphatidylinositol and of the 
insulin receptor. Insulin receptor preparation (‘wheat 
germ eluate’ [l]) corresponding to 0.16 mU IBA/assay 
was incubated in the standard phosphorylation mixture 
containing PtdIns, 0.1 mg/assay in the presence of 
increasing insulin concentrations as indicated on the 
abscissa. Lipids were extracted and counted for 
radioactivity. Protein radioactivity was measured after 
TCA precipitation, washing the precipitate 4 times with 
5% TCA/20 mM sodium pyrophosphate, and dissolving 
it in a solution cont~ning 2% SDS, 20 mM Tris and 
100 mM DTE. As judged from SDS-PAGE and 
autoradiography, over 90% of the radioactivity resided 
in the 95 kDa receptor subunit. 
seem to function as important second messengers 
the former leading to mobilisation of intracellular 
calcium [7,8], and the latter stimulating protein 
phosphorylation by activation of protein kinase C 
[9]. Our studies presented here provide strong 
evidence that the insulin receptor-associated pro- 
tein kinase, similar to the RSVpp 6O’-“” tyrosine 
kinase [lo], displays the activity of an inositol lipid 
kinase that catalyzes the phosphorylation of 
PtdIns. This may shed new light on the regulatory 
mechanisms following the binding of insulin to its 
receptor. It seems possible that the first target of 
the autophosphorylated protein kinase is 
membrane-bound PtdIns rather than some protein 
not yet detected. In our studies the major product 
of insulin-stimulated phosphorylation of PtdIns 
was PtdIns 4P while much smaller amounts of 
PtdIns 4,5 PZ were present. This may be explained 
as being due to rapid cleavage or dephosphoryla- 
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tion of the latter compound by phosphodiesterase 
or monoesterase, respectively, that may be present, 
even in purified receptor preparations. 
The release of inositol trisphosphate in our 
system has not yet been established. That inositol 
trisphosphate may in fact act as a second 
messenger of insulin is suggested from recent work 
of our laboratory showing that addition of 
micromolar concentrations of inositol trisphos- 
phate to permeabilized adipocytes leads to an acti- 
vation of pyruvate dehydrogenase quite similar to 
that observed with insulin [ 111. Moreover, insulin 
was also found to activate phospholipase C in fat 
cells [12]. 
In conclusion, present available evidence opens 
the intriguing possibility that receptor-mediated 
regulation of the polyphosphoinositide system 
plays an important role in the signal transduction 
of insulin. The idea that this may involve changes 
in the level of intracellular calcium has been 
brought forward several times yet has remained 
controversial [ 131. Tentatively, the sequence of 
events following formation of the insulin-receptor 
complex may be proposed roughly as follows: (i) 
Autophosphorylation and activation of the 
receptor-associated protein (tyrosine) kinase; (ii) 
phosphorylation of PtdIns; (iii) cleavage of PtdIns 
4,5 PZ by phospholipase C (insulin activated) 
yielding inositol trisphosphate and diacylglycerol; 
(iv) inositol trisphosphate as messenger for 
metabolic effects (e.g., PDH activation) probably 
via Ca2+ mobilisation; (v) diacylglycerol (plus 
Ca2+) as second messenger for protein (serine) 
phosphorylation by protein kinase C. This latter 
mechanism has not yet received direct experimen- 
tal support although protein kinase C is a widely 
distributed enzyme also shown to be present in 
human placenta (T. Urumow, unpublished). 
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